Brief: Isofol Says Having Received Access To Additional Data, Co Does Not Consider It Justified To Continue Conducting AGENT Study

Isofol Medical AB (publ)

31/08/2022 16:40

Aug 31 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * ISOFOL PROVIDES UPDATE ON THE AGENT STUDY
    * ISOFOL MEDICAL - REVIEW OF STUDY DATA TO CONTINUE UNTIL CO
CAN
COMPILE FINAL STUDY REPORT, ESTIMATED TO TAKE PLACE DURING Q4
    * ISOFOL MEDICAL - HAVING RECEIVED ACCESS TO ADDITIONAL
DATA, CO
DOES NOT CONSIDER IT JUSTIFIED TO CONTINUE CONDUCTING AGENT
STUDY
    * ISOFOL MEDICAL AB (PUBL) - CO'S BOARD HAS DECIDED TO
EVALUATE
POSSIBLE COURSES OF ACTION FOR COMPANY'S FUTURE IN ORDER TO
MAXIMIZE ITS VALUE

Source text for Eikon:  ID:nWkrbS1ZXg 
Further company coverage:  ISOFOL.ST 

 ((reuters.briefs@thomsonreuters.com;))